Pemphigoid gestationis: Difference between revisions

Latest revision as of 02:11, 3 August 2020

Prednisolone 0.5 mg/kg/d into the postpartum period, then titrate down
- May flare post-partum
Second-line is azathioprine

@@ Line 1: / Line 1: @@
-== Epidemiology ==
+== Background ==
+===Epidemiology===
-* 1 in 50,000 pregnancies
+*1 in 50,000 pregnancies
-== Clinical Presentation ==
+==Clinical Manifestations==
-* Very itchy bullous or vesicular rash
-* Typically starts periumbilically and spreads
-* Starts in the second half of pregnancy, may flare post-partum
+*Very itchy [[Bullous rash|bullous]] or [[vesicular rash]]
-== Diagnosis ==
+*Typically starts periumbilically and spreads
+*Starts in the second half of pregnancy, may flare post-partum
+==Diagnosis==
-* Skin biopsy
+*Skin biopsy
-== Management ==
+==Management==
-* Prednisolone 0.5 mg/kg/d into the postpartum period, then titrate down
-** May flare post-partum
-* Second-line is azathioprine
+*[[Is treated by::Prednisolone]] 0.5 mg/kg/d into the postpartum period, then titrate down
-== Prognosis and Complications ==
+**May flare post-partum
+*Second-line is [[azathioprine]]
+==Prognosis and Complications==
-* 10% risk of neonatal pemphigoid
-* Associated with other autoimmune disorders
+*10% risk of [[neonatal pemphigoid]]
+*Associated with other autoimmune disorders
 [[Category:Dermatology]]